Defying FDA: Shanghai Lab Gets Warning Letter But Won’t Relent
A Shanghai testing laboratory has been handed an FDA warning letter for refusing a GMP inspection but has shot back at the US agency, saying it rightfully did so.
You may also be interested in...
A regulatory pathway set up in China post-SARS is under stress test in the latest coronavirus outbreak, while emergency measures adopted by the country's regulator mean it’s much less burdensome to obtain approvals than before.
In a drastic move, China sends top physicians from around the country to Wuhan, finally allows a WHO expert delegation to visit hospitals in the outbreak's epicenter and welcomes foreign experts.